Reply  by Hammer, Frank Dieter
LETTERS TO THE EDITOR
Regarding “Cerebral microembolization after
protected carotid artery stenting in surgical high-risk
patients: results of a 2-year prospective study”
Hammer et al1 have performed an elegant study of the true
incidence of cerebral lesions after carotid artery stenting (CAS). Most
of the microinfarctions that were noted had no clinical consequences,
but the authors correctly point out that the late effects of these
“silent” infarctions on cognitive function are unknown.
The authors, as well as the invited commentators, both con-
clude that endovascular manipulation of the internal carotid artery
(ICA) is not responsible for these subclinical lesions. This is based
on the fact that the topography of the microinfarctions was not
limited to the territory of the stented ICA. Instead, blame is placed
on manipulations of the aortic arch or common carotid arteries
(CCAs). This absolution of ICA stenting appears to us to be rather
disingenuous, because aortic and CCA manipulation cannot be
separated from the specific technique of carotid dilation.
In any event, we question whether the observed lesions were
indeed independent of the CAS itself. According to the data
presented, 14 patients had ipsilateral lesions (8 alone and 6 associ-
ated with other lesions), while 7 had lesions elsewhere than in the
ipsilateral hemisphere. In other words, there were almost two times
more microinfarctions in the ipsilateral hemisphere, especially if we
note that one of the seven patients with contralateral lesions had
complete occlusion of that side’s CCA and could not, therefore,
have had embolization originating from it. Furthermore, that
patient had a patent anterior communicating artery. Thus, even
though it is clear that some microembolization originates from
other than ICA manipulations, the significantly higher incidence
of ipsilateral lesions forces us to consider the role of intra-ICA
manipulations themselves.
We therefore cannot be completely reassured concerning the
innocuousness of ICA manipulations, nor can we share the com-
mentators’ optimism in emphasizing the specific precautions used
in their center (minimization of aortic arch manipulation, meticu-
lous technique, and so on). These comments raise the question
that every reader asks: “under the optimized conditions at your
center, what is the real incidence of microinfarctions?”
While we again congratulate the authors for their comprehen-
sive study, we also regret that once again the utility of carotid
interventions (carotid endarterectomy [CEA] or CAS) for asymp-
tomatic stenoses (66% of patients) and in elderly patients (41%
older than 75 years) is not discussed. The Asymptomatic Carotid
Surgery Trial study showed a beneficial effect of CEA that was
limited to a 2.5% reduction in the incidence of cerebrovascular
accidents over 5 years.2 Furthermore, this marginal benefit became
apparent (under the best operative conditions) only after 2 years.
If the cost of this limited benefit (assuming that CAS has the
same effects as CEA) is a 40% incidence of silent microinfarction,
one would be justified in doubting the rationale of performing
CAS in asymptomatic elderly patients. Indeed, one might wonder
if these microembolizations hasten the onset, or worsen the sever-
ity, of senile dementia.
Raymond Limet, MD
Department of Surgery
University of Liège
Belgium
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Reply
We appreciate the letter from Pr. R. Limet, but we want to
clarify the following points. First, we have not concluded that
“endovascular manipulations of the internal carotid artery are not
responsible for subclinical lesions.”
From our study we can conclude that a significant number of
focal diffusion–weighted imaging (DWI) lesions could have re-
sulted only from manipulations in the aortic arch or arch vessels,
especially the lesions located in brain territories other than the
ipsilateral anterior circulation. The exact number of positive DWI
cases was, we must correct Pr. Limet’s numbers, 8 for ipsilateral
brain lesions, 6 for a combination of ipsilateral and other territo-
ries, and 7 for lesions located exclusively in other vascular territo-
ries. Migration through the circle of Willis seems to play a minor
role, according to our analysis of intracranial angiograms. Patients
who had a contralateral common carotid catheterization for diag-
nostic purposes only, by using a 4F catheter, had a rate of ipsilateral
DWI lesions of 33%, in comparison to 9.4% when this artery was
not probed. Its seems therefore logical to find a higher incidence of
microembolization in the ipsilateral brain when treating an internal
carotid artery (ICA) stenosis, because the endovascular maneuvers
are more aggressive: placement of a stiff exchange wire, cannula-
tion of the common carotid artery (CCA) with a 6F sheath
positioned close to the CCA bifurcation, repeated contrast injec-
tions and flushes, advancement of a folded filter device (external
diameter, 2.9-3.9F) through the ICA stenosis, and retrieval of the
filter (during which material can be pressed through the filter pores
or meshwork). On top of this comes, obviously, the stenting and
dilation itself. We admit that this step of the procedure cannot be
dissociated from most of the other maneuvers, but we do not know
how many new DWI lesions this generates, which supposes that
some emboli are not captured by the filter or pass between the
arterial wall and the filter. From a theoretical point of view, an
elegant way to assess this would be to perform a study comparing
filters with flow-reversal devices (Parodi antiembolism system). In
addition, we do not know what kind of emboli (thrombus, air, or
atheroma) can induce small incidental DWI lesions and how large
the fragments have to be. According to animal studies,1 it seems
possible that fragments even smaller than the pores of filters, which
therefore cannot be captured, could induce such lesions. This
could explain why we found no significant difference in ipsilateral
DWI lesions whether the filters contained macroscopic debris or
not after the procedures (28% vs 24%).
Carotid artery stenting (CAS) obviously requires adequate
training and an adequate environment. Unnecessary catheteriza-
tion of other arch vessels should be avoided and certainly can
reduce the overall rate of DWI lesions. Technical skills alone can
probably to a large extent not avoid such lesions. We observed,
for example, no reduction of the number of DWI lesions over
the 2 years of our patient inclusion: 11 positive cases in the 27 first
patients of this study vs 10 in the 26 last patients.
We are convinced, according to our data, that since the
introduction of protective devices too much attention has been
placed on the carotid lesions themselves and their structure to
explain or try to predict cerebral embolization during CAS. Be-
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cause it seems that the femoral approach will remain the privileged
route for endovascular treatment of ICA stenoses, a direct punc-
ture of the CCA carrying a too-important risk of complications,
especially in patients premedicated with antiaggregants and hepa-
rin, we are not particularly optimistic about seeing an important
reduction of DWI lesions in the future. The only way to reassure
us would be to demonstrate that those lesions are innocuous—
especially that they induce no negative effects on cognitive func-
tions or acceleration of intellectual decline.
Second, concerning the utility of carotid interventions in
asymptomatic patients, we agree that this topic is still controversial
and that the indications have to be restrained. Local center exper-
tise and complication rates, the patient’s condition and life expect-
ancy, and the degree of ipsilateral and contralateral stenosis are
some of the key points that need to be assessed. The group of
asymptomatic patients who we treated was carefully selected on the
basis of local and general criteria, and we considered, after a
multidisciplinary discussion, that CAS was a better alternative than
surgery or conservative management.
We did not treat patients who were elderly and asymptom-
atic. The asymptomatic group was in fact significantly younger
than the symptomatic group (mean age, 69.5 vs 77.7 years) and
had in general a good life expectancy. Their stenoses were very
tight and bilateral in 46% of the cases. Twenty-nine percent of
the patients had a hostile neck that precluded any surgical
procedure. Forty-three percent had to undergo cardiac surgery
in the near future, and in this group of patients, we considered
that CAS followed within several days or weeks by cardiac
surgery was potentially less invasive than a combined carotid
and cardiac surgical procedure, which is known to carry a higher
rate of mortality and morbidity.
Finally, none of these highly selected asymptomatic patients
had a neurologic deficit, and their rate of new silent DWI lesions
was less than that in the symptomatic group (34% vs 50%). We
therefore think that our attitude was justified, but we agree that the
indications to treat them must be restrictive and that the follow-up
is very important.
Third, observation of such a high incidence of focal DWI
lesions, especially in asymptomatic patients, should indeed be a
concern. Fortunately, a recent study2 has demonstrated that
most of those DWI lesions (97%) do not evolve to macroscopic
brain infarction and are nondetectable on magnetic resonance
imaging follow-up examinations at 6 months. In addition,
stenting of the ICA stenosis could prevent further embolization
from the carotid plaque and, in some cases, restore cerebral
perfusion, therefore potentially improving some cerebral cogni-
tive functions. This remains nevertheless speculative, and when
considering the high rate of DWI lesions, we definitively agree
with Pr. Limet that the short- and long-term evolution of
cognitive functions in CAS patients needs to be evaluated and
compared with carotid endarterectomy.
Frank Dieter Hammer, MD
University Hospital St. Luc
Brussels, Belgium
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Regarding “Autogenous radial-cephalic or prosthetic
brachial-antecubital forearm loop AVF in patients
with compromised vessels? A randomized multicenter
study of the patency of primary hemodialysis access”
The article of Rooijens et al1 promotes the placement of
brachial-antecubital forearm loop prosthetic grafts when forearm
arteries and veins are judged unsuitable for the creation of a native
fistula in dialysis patients. They wrote in the introduction that no
information was available on the performance of alternative ac-
cesses in patients with poor or questionable forearm vessels, that
“an upper arm direct AVF, anastomosing the brachial artery with
the cephalic or basilic vein, may be a second best option after failure
of a radial-cephalic AVF, but that in K/DOQI guidelines no
consensus for either this option or the implantation of a prosthetic
graft implant has been outlined.” This statement is false, since
DOQI guideline number 3 clearly outlines that a prosthetic graft
should be placed only “if a wrist radial-cephalic fistula or an elbow
brachial-cephalic fistula cannot be constructed.”2
Therefore, we do not believe that Rooijens et al have ad-
dressed the major issue, which is not to determine whether grafts
fare better than forearm fistulas but whether they fare better than
direct brachial-cephalic fistulas. In fact, the review of the literature
by the authors of the DOQI guidelines demonstrated the latter.
In addition, the authors have overlooked the fact that forearm
prosthetic grafts invariably result in the development of a stenosis
at the venous anastomosis located at the elbow level, which then
often precludes the use of the cephalic or basilic vein for creation of
a direct elbow fistula. Finally, primary placement of a graft is rarely
reversible, whereas failed native fistulas leave the door open for
secondary or tertiary prosthetic grafts. For these reasons, we dis-
agree with the authors that forearm grafts should be placed before
brachial level fistulas.
Luc Turmel-Rodrigues, MD
Pierre Bourquelot, MD
Clinique Saint-Gatien
Tours, France
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Reply:
The radial-cephalic direct wrist arteriovenous fistula (RCAVF)
is the primary and best option for vascular access in patients who
need long-term intermittent hemodialysis, as proposed by the
National Kidney Foundation-Kidney Disease Outcomes Quality
Initiative guidelines. However, in patients with poor or question-
able forearm vessels, an alternative vascular access may be consid-
ered.
We agree that an antecubital brachial-cephalic fistula is a good
second option, but there are still no good studies available that
support this alternative access. On the other hand, before starting
the current study, only few data were known on the outcome of
RCAVFs in patients with poor or questionable vessels, and no
information on the performance of prosthetic arteriovenous grafts
in these patients were available. That is the reason why we per-
formed this study.
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